Filing Flows

Filing Flows › Tenaya Therapeutics (TNYA) › Next earnings date

Tenaya Therapeutics (TNYA) earnings: beat the estimate

Tenaya Therapeutics (TNYA) reported on Nov 4, 2026 and beat the EPS estimate: −$0.08 against −$0.10 (+15.3%). Revenue was $1.7M for Q3 2026. It beat the EPS estimate in 60% of the quarters on record.

Last result+15.3% vs estimate
Beat rate60%

The last report

Tenaya Therapeutics reported revenue of $1.7M for the third quarter 2026, net loss $18.9M. How it makes money → · Every quarter →

Tenaya Therapeutics: EPS against the estimate, last 5 reportsTenaya Therapeutics: EPS against the estimate, last 5 reportsEstimateReported−$0.15−$0.12Nov 25−$0.12−$0.12Mar 26−$0.09−$0.09May 26−$0.07−$0.09Aug 26−$0.10−$0.08Nov 26
Latest (Nov 26): Estimate −$0.10, Reported −$0.08.

Tenaya Therapeutics' latest quarter

Tenaya Therapeutics, Q3 2026: revenue $1.7M, net loss $18.9M, operating cash flow −$17.7M. The chart follows the revenue to costs, profit and cash.

Questions

Did Tenaya Therapeutics beat earnings?

Tenaya Therapeutics (TNYA) reported on Nov 4, 2026 and beat the EPS estimate: −$0.08 against −$0.10 (+15.3%).

When does TNYA report earnings?

The next date is not set yet.

Does Tenaya Therapeutics usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.